Differentiation of Alzheimer's, Huntington's, and Parkinson's Disease Patients on the Basis of Verbal Learning Characteristics

被引:49
|
作者
Kramer, Joel H. [1 ]
Levin, Bonnie E. [2 ]
Brandt, Jason [3 ]
Delis, Dean C. [4 ,5 ]
机构
[1] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA
[2] Univ Miami, Sch Med, Miami, FL USA
[3] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[4] VA Med Ctr, San Diego, CA USA
[5] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA
关键词
Cortical dementia; subcortical dementia; verbal learning; California; Verbal Learning Test; Alzheimer's disease; Parkinson's disease; Huntington's disease;
D O I
10.1037//0894-4105.3.2.111
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
This study examined the degree to which patients with dementia could be differentiated on the basis of their verbal learning characteristics. Patients with Parkinson's disease (PD), Huntington's disease (HD), and probable Alzheimer's disease (AD) were administered the California Verbal Learning Test. PD and HD patients were divided into subgroups to control for the severity of overall memory impairment. Discriminant function analysis correctly categorized over 76% of cases. Intrusions, perseverations, and rate of forgetting were the most discriminating variables. Profile differences between HD and PD were sufficiently robust to separate these two groups with reasonable accuracy. These results do not support a simplistic cortical-subcortical dichotomy; rather, individual dementing syndromes have unique patterns of verbal learning performance that are distinct from one another.
引用
收藏
页码:111 / 120
页数:10
相关论文
共 50 条
  • [31] Firing rates of pallidal neurons are similar in Huntington’s and Parkinson’s disease patients
    Joyce K. H. Tang
    Elena Moro
    Andres M. Lozano
    Anthony E. Lang
    William D. Hutchison
    Neil Mahant
    Jonathan O. Dostrovsky
    Experimental Brain Research, 2005, 166 : 230 - 236
  • [32] Firing rates of pallidal neurons are similar in Huntington's and Parkinson's disease patients
    Tang, JKH
    Moro, E
    Lozano, AM
    Lang, AE
    Hutchison, WD
    Mahant, N
    Dostrovsky, JO
    EXPERIMENTAL BRAIN RESEARCH, 2005, 166 (02) : 230 - 236
  • [33] Are Parkinson's Disease Patients the Ideal Preclinical Population for Alzheimer's Disease Therapeutics?
    Tropea, Thomas F.
    Chen-Plotkin, Alice
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (09):
  • [34] Shared perturbations in the metallome and metabolome of Alzheimer's, Parkinson's, Huntington's, and dementia with Lewy bodies: A systematic review
    Scholefield, Melissa
    Unwin, Richard D.
    Cooper, Garth J. S.
    AGEING RESEARCH REVIEWS, 2020, 63
  • [35] Application of the Japanese Verbal Learning Test to Patients With Alzheimer's Disease in the Early Stage
    Matsui, Mie
    Matsuoka, Tadasu
    Suzuki, Michio
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [36] Olfactory evoked potentials in Parkinson's disease, Alzheimer's disease and anosmic patients
    Sakuma, K
    Nakashima, K
    Takahashi, K
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 1996, 50 (01) : 35 - 40
  • [37] Responses to donepezil in Alzheimer's disease and Parkinson's disease
    Mori, S
    ALZHEIMER'S DISEASE: VASCULAR ETIOLOGY AND PATHOLOGY, 2002, 977 : 493 - 500
  • [38] Role of epigenetics in Alzheimer's and Parkinson's disease
    Kwok, John B. J.
    EPIGENOMICS, 2010, 2 (05) : 671 - 682
  • [39] Alzheimer's and Parkinson's disease therapies in the clinic
    Chopade, Puja
    Chopade, Neha
    Zhao, Zongmin
    Mitragotri, Samir
    Liao, Rick
    Suja, Vineeth Chandran
    BIOENGINEERING & TRANSLATIONAL MEDICINE, 2023, 8 (01)
  • [40] Comparison of proline endopeptidase activity in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease
    Mantle, D
    Falkous, G
    Ishiura, S
    Blanchard, PJ
    Perry, EK
    CLINICA CHIMICA ACTA, 1996, 249 (1-2) : 129 - 139